Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

Clinical trial NCT05688280 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05688280
Sponsor: Immunophotonics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Solid Tumor Colon Cancer Nonsmall Cell Lung Cancer Soft Tissue Sarcoma

Start date: 2022-11-29
Primary completion: 2025-02-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.